BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4765746)

  • 1. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
    Masuoka DT; Alcaraz AF
    Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
    Luthman J; Brodin E; Sundström E; Wiehager B
    Int J Dev Neurosci; 1990; 8(5):549-60. PubMed ID: 1704172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.
    Hedreen JC; Chalmers JP
    Brain Res; 1972 Nov; 47(1):1-36. PubMed ID: 4345031
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition of 3 H-biogenic amine uptake by 5,6-dihydroxytryptamine: a comparison with the effects of 6-hydroxydopamine.
    Heikkila RE; Cohen G
    Eur J Pharmacol; 1973 Jan; 21(1):66-9. PubMed ID: 4709207
    [No Abstract]   [Full Text] [Related]  

  • 7. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine.
    Jonsson G; Pycock C; Fuxe K; Sachs C
    J Neurochem; 1974 Mar; 22(3):419-26. PubMed ID: 4829965
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake of 5-hydroxytryptamine by Schistosoma mansoni.
    Bennett JL; Bueding E
    Mol Pharmacol; 1973 May; 9(3):311-9. PubMed ID: 4267956
    [No Abstract]   [Full Text] [Related]  

  • 11. Ontogeny of monoamine neurons in the locus coeruleus, Raphe nuclei and substantia nigra of the rat. I. Cell differentiation.
    Lauder JM; Bloom FE
    J Comp Neurol; 1974 Jun; 155(4):469-81. PubMed ID: 4847734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of brain norepinephrine by intraventricular injection of 6-hydroxydopa: a biochemical, histochemical and behavioral study in rats.
    Richardson JS; Jacobowitz DM
    Brain Res; 1973 Aug; 58(1):117-33. PubMed ID: 4740976
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse.
    Jonsson G; Nwanze E
    Br J Pharmacol; 1982 Oct; 77(2):335-45. PubMed ID: 7139192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced brain monoamine depletion and its behavioral correlates in Caiman sclerops.
    Doshi E; Huggins SE
    Comp Biochem Physiol C Comp Pharmacol; 1977; 57(2):153-7. PubMed ID: 20272
    [No Abstract]   [Full Text] [Related]  

  • 17. Biogenic amine terminals in the goldfish cerebellum and optic tectum: a fluorescence and autoradiographic study.
    Niso R; Villani L; Contestabile A; Ciani F
    Basic Appl Histochem; 1981; 25(2):113-9. PubMed ID: 7271702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental characteristics of central monoamine neurons and their reciprocal relations.
    Jonsson G
    Exp Neurol; 1976 Dec; 53(3):801-14. PubMed ID: 1001399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Localization of biogenic amines in the rat spinal cord. A fluorescence histochemical study after intraventricular injection of L-dopa (author's transl)].
    Chouchkov CN
    Histochemistry; 1974; 41(2):167-73. PubMed ID: 4374457
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a butyrophenone derivative, U-32,802A, on brain biogenic amines.
    Lahti RA; Lednicer D
    Biochem Pharmacol; 1974 Jun; 23(12):1701-5. PubMed ID: 4842658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.